Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • AALL1732 A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494 NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL Mixed Phenotype Acute Leukemia and Disseminated B-LLy

    The purpose of the study is to determine the safety and efficacy of the investigational medicine Inotuzumab Ozogamicin for patients who have NCI high risk ...

    View Details

  • A Phase 3 Global Double-Blind Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy

    The purpose of this study is to evaluate the safety of ION-682884 and determine if it can help people with cardiomyopathy.ION-682884 is an investigational ...

    View Details

  • Sleep and Prediabetes Project

    The purpose of this research study is to compare the effects of individual counseling to improve sleep, eating habits, and physical activity versus individual counseling ...

    View Details

  • Multi-Center Prospective Evaluation of Complex Adult Spinal Deformity Surgery (CADS)

    The purpose of this study is to evaluate the surgical outcomes of adults with complex spinal deformity at multiple centers across the United States. While ...

    View Details

  • Microbial and human biomarkers of thoracic disease after lung transplantation

    The purpose of this study is to identify biological markers associated with lung inflammation and immune responsiveness in lung transplantation. The study will prospectively collect ...

    View Details

  • A Phase 2 Umbrella Study with Rolling Arms of Investigational Agents with either Pembrolizumab in Combination with Chemotherapy or with Pembrolizumab Alone in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

    The purpose of the study is to determine how well different drugs work in a single type of cancer for patients with advanced NSCLC. This ...

    View Details

  • A Phase 3 Open-label Extension Study to Assess the Long-term Safety and Efficacy of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe Disease

    The purpose of this study is to find out if an investigational new drug called ATB200 and AT2221 can help people with Pompe disease and ...

    View Details

  • Multicenter Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy Safety and Tolerability of 36 weeks of treatment with NLY01 in Early-Stage Parkinson s Disease

    Parkinson’s disease is a condition that interferes with body movement. The condition usually worsens over time. Research suggests that inflammation in certain areas of ...

    View Details